Related Experiment Video
Updated: Jun 16, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity
Shannon Levesque1, Belinda Wilson, Vincent Gregoria
1Department of Anatomy & Neurobiology, Sanger Hall, Room 9-048, 1101 E. Marshall Street, Virginia Commonwealth University Medical Campus, Box 980709, Richmond, VA 23298-0709, USA.
Abstract:
Microglia, the innate immune cells in the brain, can become chronically activated in response to dopaminergic neuron death, fuelling a self-renewing cycle of microglial activation followed by further neuron damage (reactive microgliosis), which is implicated in the progressive nature of Parkinson's disease. Here, we use an in vitro approach to separate neuron injury factors from the cellular actors of reactive microgliosis and discover molecular signals responsible for chronic and toxic microglial activation. Upon injury with the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium, N27 cells (dopaminergic neuron cell line) released soluble neuron injury factors that activated microglia and were selectively toxic to dopaminergic neurons in mixed mesencephalic neuron-glia cultures through nicotinamide adenine dinucleotide phosphate oxidase. mu-Calpain was identified as a key signal released from damaged neurons, causing selective dopaminergic neuron death through activation of microglial nicotinamide adenine dinucleotide phosphate oxidase and superoxide production. These findings suggest that dopaminergic neurons may be inherently susceptible to the pro-inflammatory effects of neuron damage, i.e. reactive microgliosis, providing much needed insight into the chronic nature of Parkinson's disease.
Insights
Parkinson's disease involves chronic microglial activation and neuron damage. Researchers identified mu-Calpain from damaged neurons as a key signal that triggers this toxic microglial response.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglia, the brain's immune cells, contribute to Parkinson's disease progression through chronic activation (reactive microgliosis).
- This cycle of microglial activation and neuron damage is a hallmark of Parkinson's disease pathology.
Purpose of the Study:
- To identify molecular signals responsible for chronic and toxic microglial activation in Parkinson's disease.
- To elucidate the mechanisms underlying reactive microgliosis in dopaminergic neuron degeneration.
Main Methods:
- Utilized an in vitro model to isolate neuron injury factors from cellular components of reactive microgliosis.
- Exposed N27 dopaminergic neuron cell lines to 1-methyl-4-phenylpyridinium and analyzed released factors in mixed neuron-glia cultures.
Main Results:
- Damaged N27 cells released soluble factors that activated microglia and were toxic to dopaminergic neurons via nicotinamide adenine dinucleotide phosphate oxidase.
- Identified mu-Calpain as a critical signal from damaged neurons, inducing dopaminergic neuron death through microglial activation of nicotinamide adenine dinucleotide phosphate oxidase and superoxide production.
Conclusions:
- Dopaminergic neurons are susceptible to pro-inflammatory effects of neuron damage, contributing to reactive microgliosis.
- Mu-Calpain signaling from damaged neurons drives chronic microglial activation, offering insight into Parkinson's disease progression.
